Artemotil
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(5aS,6R,8aS,9R,10S,12R,12aR)-10-ethoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| Routes of administration | Intramuscular injection |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Biological half-life | 20 hours |
| Identifiers | |
| CAS Number |
75887-54-6 |
| ATC code | P01BE04 (WHO) |
| PubChem | CID 3000469 |
| ChemSpider |
2272064 |
| UNII |
XGL7GFB9YI |
| ChEMBL |
CHEMBL301267 |
| Chemical data | |
| Formula | C17H28O5 |
| Molar mass | 312.401 g/mol |
| |
| |
| | |
Artemotil (INN; also known as β-arteether), is a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases. It is a semi-synthetic derivative of artemisinin, a natural product of the Chinese plant Artemisia annua. It is currently only used as a second line drug in severe cases of malaria.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
